Sever Pharma Solutions Expands Capabilities with Approval of New Aseptic Filling Line for High Potent Injectable Drugs in Malmo Site

MALMO, [2023-10-18] – Sever Pharma Solutions, a leading provider of pharmaceutical contract manufacturing and development solutions, is pleased to announce the approval by the Swedish Health authorities of its state-of-the-art aseptic filling line for syringes, specifically designed for high potent injectable drugs, at its Malmo site. This significant expansion of capabilities reinforces Sever Pharma Solutions’ commitment to delivering innovative solutions that meet the growing demands of the pharmaceutical industry.

The new aseptic filling line represents a substantial investment in advanced technology and infrastructure, positioning Sever Pharma Solutions at the forefront of pharmaceutical manufacturing excellence. This modern line is equipped with the latest automated systems and quality control measures, ensuring the highest levels of safety, efficiency, and product integrity. By employing stringent aseptic techniques and advanced barrier systems, Sever Pharma Solutions guarantees the sterility and purity of the drugs being filled, maintaining their potency throughout the entire process.

Sever Pharma Solutions’ new aseptic filling line is specifically designed for syringes, providing pharmaceutical companies with a reliable and efficient solution for producing high potent injectable drugs. This advanced system enhances the company’s manufacturing capacity and allows for seamless integration with its assembly solutions for auto-injectors.

These cutting-edge systems ensure the precise and reliable assembly of auto-injectors, meeting the highest industry standards. By co-locating the filling line and assembly solutions, Sever Pharma Solutions offers a streamlined and comprehensive manufacturing process, facilitating cost-effective and efficient production for its clients.

“We are thrilled to announce the approval of our new aseptic filling line for syringes, designed specifically for high potent injectable drugs,” said Kenneth Stokholm, CEO at Sever Pharma Solutions. “This investment showcases our commitment to innovation and our dedication to meeting the evolving needs of our clients in the pharmaceutical industry. Integrating our state-of-the-art assembly lines for auto-injectors further strengthens our position as a comprehensive solution provider, enabling us to deliver unparalleled quality and value.”

Sever Pharma Solutions’ expansion in Malmo underscores its commitment to continuous improvement and advancement in pharmaceutical manufacturing. The company remains focused on leveraging advanced technologies and adhering to the highest industry standards, ensuring the production of safe and effective drug products for patients worldwide.